Description
This CPD certified e-learning course is aimed at medicines optimisation teams, GPs, practice nurses, practice pharmacists, PCN pharmacists, care home pharmacists and pharmacy technicians.
The course is broken down into 10 modules including:
- Introduction
- Cholesterol and hypercholesterolaemia
- NICE Guideline 238
- Statins
- Ezetimibe
- PCSK9 inhibitors
- Bempedoic acid
- Inclisiran
- Icosapent ethyl
- National guidance for lipid management
There are also three practical case studies which consider statins for primary prevention, secondary prevention and statin intolerance.
The course should take around 3 hours in total to complete, but we recommend that it is taken in stages and not in a single sitting.
Quizzes at the end of each module will test understanding and recap on key learning points, and a pass mark of 70% is required in the final assessment to complete the course and receive a certificate.
This e-learning course was last updated in May 2023 and does not yet incorporate the new recommendations in NICE guideline 238, published in December 2024. The course will be updated early in 2024 to reflect the new recommendations.
Our user testers say:
“An easy to use and to follow course, that takes you through all the NICE guidance and evidence base around the targets and treatments for lipid modification and embedding learning by case studies and self assessment. With the recent introduction of new agents this course is particularly valuable.”
“A well-written resource that will bring you right up to date; describes new treatment options in lipid modification and when to use which product, including all the latest evidence to support your clinical practice. Useful as a refresher for experienced clinicians and a learning tool for new CV practitioners.”
